CVRX INC. - COMMON STOCK

CVRx Reports First Quarter 2025 Financial and Operating Results

08 May 2025 13:05:01 By Nasdaq GlobeNewswire

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

24 Apr 2025 13:30:00 By Nasdaq GlobeNewswire

CVRx Reports Preliminary First Quarter 2025 Financial Results

07 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

12 Feb 2025 11:45:00 By Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

04 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

21 Jan 2025 13:30:00 By Nasdaq GlobeNewswire

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance

13 Jan 2025 05:00:01 By Nasdaq GlobeNewswire

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

23 Dec 2024 13:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 13:30:00 By Nasdaq GlobeNewswire

CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025

04 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

CVRx Reports Third Quarter 2024 Financial and Operating Results

29 Oct 2024 13:05:00 By Nasdaq GlobeNewswire

CVRx announces new CPT® Category I codes for Barostim

18 Oct 2024 11:08:11 By Nasdaq GlobeNewswire

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

15 Oct 2024 13:30:00 By Nasdaq GlobeNewswire

CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim

12 Sep 2024 05:00:00 By Nasdaq GlobeNewswire

CVRx Announces Appointment of Two New Board Members

03 Sep 2024 05:30:00 By Nasdaq GlobeNewswire

CVRx Announces Increased Inpatient Payment for Barostim Procedure

02 Aug 2024 05:00:00 By Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference

31 Jul 2024 13:27:00 By Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2024 Financial and Operating Results

29 Jul 2024 13:05:00 By Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

15 Jul 2024 13:30:00 By Nasdaq GlobeNewswire

CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer

25 Jun 2024 03:50:00 By Nasdaq GlobeNewswire